Results 191 to 200 of about 12,292,416 (404)
From Slovak Academy of Sciences and Arts to Slovak Academy of Sciences [PDF]
Štefan Drug
doaj
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
J. S. Suk +4 more
semanticscholar +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha +10 more
wiley +1 more source
A Trial of Five Tranquillizing Drugs in Psychoneurosis [PDF]
Marie Raymond +4 more
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Pharmacographia. A history of the principal drugs of vegetable origin, met with in Great Britain and British India. By Friedrich A. Flückiger, Phil. Dr., Professor in the University of Strassburg, and Daniel Hanbury, F. R. S., Fellow of the Linnean and Chemical Societies of London. Second edition. Macmillan and Co. 1879. 803 S. in Octav. [PDF]
Th. Husemann
openalex +1 more source

